Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells
Researchers are testing a dual-targeting GPNMB CAR-T cell therapy to treat aggressive glioblastoma and its supporting immune cells.
📍 The outcome
Researchers developed an immunotherapy strategy using GPNMB CAR T cells to simultaneously target glioblastoma and immune cells. This experimental treatment showed promise in reducing rare cancerous tumors and eliminating aggressive glioblastoma.
The story quieted without a definitive conclusion in the coverage.
Epilogue added 42d ago, after coverage quieted.
What happened
A new immunotherapy strategy utilizing GPNMB CAR-T cells is being developed to combat aggressive glioblastoma. This approach employs dual targeting to attack both the brain tumors and their myeloid immune cell accomplices.
Coverage from Nature, Medical Xpress, and Labmate-Online emphasizes the use of cytokine-armoured cells and the potential for this therapy to eliminate deadly brain cancers. The Telegraph and News-Medical further highlight the promise of this immunotherapy in treating one of the deadliest forms of cancer.
Future developments will center on the effectiveness of these CAR-T cells in eliminating glioblastoma and the impact of the cytokine-armoured delivery system.
Synthesized by Newsylist from the headlines below under a strict no-invention contract. ✓ fact-checked: all claims supported by sources Updated 47d ago.
Who reported it (15)
- Beeta Benjy: What is the Missing Puzzle Piece of CAR-T Therapy Failure in Solid Tumors? Oncodaily · 47d ago
- Engineered Immunotherapy Improves Treatment for Brain Cancer Labroots · 47d ago
- CAR T Cells Simultaneously Target Glioblastoma and Immune Cells Inside Precision Medicine · 47d ago
- New Therapy Could Target One of the Deadliest Brain Cancers Newsweek · 47d ago
- Community giving powers a UCalgary cancer immunotherapy breakthrough University of Calgary · 47d ago
- U of C-developed experimental treatment reduces rare cancerous tumours Calgary Herald · 47d ago
- New immunotherapy developed at the University of Calgary being used to treat solid cancerous tumours University of Calgary · 47d ago
- With GPNMB, CAR T makes further inroads in solid tumors BioWorld News · 47d ago
- Immunotherapy Strategy Shows Promise for Deadly Brain Cancer Northwestern University · 47d ago
- McMaster-Developed Immunotherapy Strategy Targets Aggressive Brain Tumours and Their Fuel Newswise · 47d ago
- CAR-T cell therapy shows potential to eliminate aggressive glioblastoma News-Medical · 47d ago
- Cytokine-armoured CAR T therapy shows promise against aggressive glioblastoma Labmate-Online · 47d ago
- New immunotherapy strategy targets aggressive brain tumors and their immune cell accomplices Medical Xpress · 47d ago
- Deadliest brain cancer could be treated with immunotherapy The Telegraph · 47d ago
- Dual tumour–myeloid targeting of glioblastoma with GPNMB CAR-T cells Nature · 47d ago broke it first
Questions people are asking
What is the specific target of this CAR-T therapy?
The therapy uses GPNMB CAR-T cells for dual tumour-myeloid targeting.
What makes this immunotherapy strategy different?
According to coverage, the strategy targets both the aggressive brain tumors and their immune cell accomplices using cytokine-armoured cells.
Which condition is this treatment designed to address?
The therapy is designed to treat glioblastoma, described in coverage as an aggressive and deadly brain cancer.
Momentum
How fast coverage is spreading — measured hourly from article rate × source diversity. How this works →
People, places & organizations
Topics
Related trends
CRISPR makes prostate cancer vulnerable to immunotherapy
New CRISPR gene-editing research indicates a method to improve the immune system's ability to detect and target prostate cancer tumors.
Humanity spoke thousands of languages at the dawn of farming
Researchers are exploring a linguistic 'golden age' where humans spoke thousands more languages than they do today.
Study Shows Rapid Reversal of Autism Traits
A single dose of rapamycin has been shown to reverse autism-like brain changes and traits in adult mice within hours.
Astronomers may have discovered the 1st moon outside of our solar system
Astronomers report the potential detection of the first known exomoon orbiting a substellar companion outside our solar system.
Only 13% survive this cancer. A blood test just detected 90% of early cases
A new blood gene test has demonstrated the ability to detect 90% of early-stage pancreatic cancers, a disease with a 13% survival rate.
One Fungus Has Caused More Extinctions Than Any Other Infectious Disease. Some Toads Have Found a Way to Survive It
Researchers have uncovered how certain toad populations survive a lethal fungus that has caused more extinctions than any other infectious disease.